Fenofibrate administration does not affect muscle triglyceride concentration or insulin sensitivity in humans

Metabolism: Clinical and Experimental

Volumn 60, Issue 8, 2011, Pages 1107-1114

  Perreault, Leigh ^a   Bergman, Bryan C ^a   Hunerdosse, Devon M ^a   Howard, David J ^a   Eckel, Robert H ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

[U 13C]PALMITATE; ADRENALIN; C PEPTIDE; CATECHOLAMINE; FATTY ACID; FENOFIBRATE; GLUCAGON; GLUCOSE; GLYCEROL; INSULIN; LACTIC ACID; NORADRENALIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FRACTIONAL SYNTHESIS RATE; GAS CHROMATOGRAPHY; GAS CHROMATOGRAPHY COMBUSTION ISOTOPE RATIO MASS SPECTROMETRY; HUMAN; HUMAN TISSUE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIPID METABOLISM; LIPOGENESIS; MALE; MASS SPECTROMETRY; MUSCLE BIOPSY; MUSCLE LEVEL; OBESITY; PRIORITY JOURNAL; SEX DIFFERENCE; UNSPECIFIED SIDE EFFECT;

AGED; BLOOD GLUCOSE; BODY COMPOSITION; FEMALE; FENOFIBRATE; GLUCOSE TOLERANCE TEST; HUMANS; HYPOLIPIDEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OVERWEIGHT; TRIGLYCERIDES;

EID: 79960556459     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.12.003     Document Type: Article

References (41)

1. DeFronzo R.A., Ferrannini E., Hendler R., Felig P., and Wahren J. Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man Diabetes 32 1983 35 45 (Pubitemid 13203694)
2. Baron A.D., Brechtel G., Wallace P., and Edelman S.V. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans Am J Physiol 255 1988 E769 E774
3. Goodpaster B.H., Theriault R., Watkins S.C., and Kelley D.E. Intramuscular lipid content is increased in obesity and decreased by weight loss Metabolism 49 2000 467 472 (Pubitemid 30196572)
4. Krssak M., Falk Petersen K., and Dresner A. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study Diabetologia 42 1999 113 116 (Pubitemid 29039748)
5. Pan D.A., Lillioja S., and Kriketos A.D. Skeletal muscle triglyceride levels are inversely related to insulin action Diabetes 46 1997 983 988 (Pubitemid 27220998)
6. Perseghin G., Scifo P., and De Cobelli F. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents Diabetes 48 1999 1600 1606 (Pubitemid 29356869)
7. Karakelides H., Irving B.A., Short K.R., O'Brien P., and Nair K.S. Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function Diabetes 59 2010 89 97
8. Perreault L., Bergman B.C., Hunerdosse D.M., and Eckel R.H. Altered intramuscular lipid metabolism relates to diminished insulin action in men, but not women, in progression to diabetes Obesity(Silver Spring) 18 2010 2093 2100
9. Bergman B.C., Perreault L., Hunerdosse D.M., Koehler M.C., Samek A.M., and Eckel R.H. Increased intramuscular lipid synthesis and low saturation relate to insulin sensitivity in endurance-trained athletes J Appl Physiol 108 2010 1134 1141
10. Bergman B.C., Perreault L., Hunerdosse D.M., Koehler M.C., Samek A.M., and Eckel R.H. Intramuscular lipid metabolism in the insulin resistance of smoking Diabetes 58 2009 2220 2227
11. Djouadi F., Weinheimer C.J., and Saffitz J.E. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor alpha-deficient mice J Clin Invest 102 1998 1083 1091 (Pubitemid 28436268)
12. Chou C.J., Haluzik M., and Gregory C. WY14,643, a peroxisome proliferator-activated receptor alpha (PPARalpha) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice J Biol Chem 277 2002 24484 24489 (Pubitemid 34951973)
13. Furuhashi M., Ura N., and Murakami H. Fenofibrate improves insulin sensitivity in connection with intramuscular lipid content, muscle fatty acid-binding protein, and beta-oxidation in skeletal muscle J Endocrinol 174 2002 321 329 (Pubitemid 34965771)
14. Ye J.M., Doyle P.J., Iglesias M.A., Watson D.G., Cooney G.J., and Kraegen E.W. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation Diabetes 50 2001 411 417 (Pubitemid 32127300)
15. Bergman R.N., Watanabe R.M., Rebrin K., Ader M., and Steil G.M. Toward an integrated phenotype in pre-NIDDM Diabet Med 13 1996 S67 S77
16. Bergstrom J. Percutaneous needle biopsy of skeletal muscle in physiological and clinical research Scand J Clin Lab Invest 35 1975 609 616
17. Guo Z., Mishra P., and Macura S. Sampling the intramyocellular triglycerides from skeletal muscle J Lipid Res 42 2001 1041 1048 (Pubitemid 32645784)
18. Rosendal J., and Knudsen J. A fast and versatile method for extraction and quantitation of long-chain acyl-CoA esters from tissue: content of individual long-chain acyl-CoA esters in various tissues from fed rat Anal Biochem 207 1992 63 67
19. Kaluzny M.A., Duncan L.A., Merritt M.V., and Epps D.E. Rapid separation of lipid classes in high yield and purity using bonded phase columns J Lipid Res 26 1985 135 140 (Pubitemid 15133302)
20. Patterson B.W., Zhao G., and Klein S. Improved accuracy and precision of gas chromatography/mass spectrometry measurements for metabolic tracers Metabolism 47 1998 706 712 (Pubitemid 28265176)
21. Patterson B.W., Zhao G., Elias N., Hachey D.L., and Klein S. Validation of a new procedure to determine plasma fatty acid concentration and isotopic enrichment J Lipid Res 40 1999 2118 2124 (Pubitemid 29523438)
22. Agren J.J., Julkunen A., and Penttila I. Rapid separation of serum lipids for fatty acid analysis by a single aminopropyl column J Lipid Res 33 1992 1871 1876 (Pubitemid 23006664)
23. Wolfe R. Radioative and stable isotope tracers in biomedicine: principles and practice of kinetic analysis 1992 Wiley-Liss New York
24. Blaak E.E., van Aggel-Leijssen D.P., Wagenmakers A.J., Saris W.H., and van Baak M.A. Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise Diabetes 49 2000 2102 2107
25. Paton C.M., and Ntambi J.M. Biochemical and physiological function of stearoyl-CoA desaturase Am J Physiol Endocrinol Metab 297 2009 E28 E37
26. Lee H.J., Choi S.S., and Park M.K. Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats Biochem Biophys Res Commun 296 2002 293 299
27. Nadeau K.J., Ehlers L.B., Aguirre L.E., Reusch J.E., and Draznin B. Discordance between intramuscular triglyceride and insulin sensitivity in skeletal muscle of Zucker diabetic rats after treatment with fenofibrate and rosiglitazone Diabetes Obes Metab 9 2007 714 723 (Pubitemid 47261853)
28. Abbasi F., Chen Y.D., Farin H.M., Lamendola C., and Reaven G.M. Comparison of three treatment approaches to decreasing cardiovascular disease risk in nondiabetic insulin-resistant dyslipidemic subjects Am J Cardiol 102 2008 64 69
29. Belfort R, Berria R, Cornell J, Cusi K. Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome. J Clin Endocrinol Metab 2010;95:829-836.
30. Fabbrini E., Mohammed B.S., and Korenblat K.M. Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoproteins kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease J Clin Endocrinol Metab 95 2010 2727 2735
31. Liu L., Zhang Y., Chen N., Shi X., Tsang B., and Yu Y.H. Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance J Clin Invest 117 2007 1679 1689 (Pubitemid 46871352)
32. Schenk S., and Horowitz J.F. Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance J Clin Invest 117 2007 1690 1698 (Pubitemid 46871353)
33. Toledo F.G., Menshikova E.V., and Azuma K. Mitochondrial capacity in skeletal muscle is not stimulated by weight loss despite increases in insulin action and decreases in intramyocellular lipid content Diabetes 57 2008 987 994
34. AbouRjaili G, Shtaynberg N, Wetz R, Costantino T, Abela GS. Current concepts in triglyceride metabolism, pathophysiology, and treatment. Metabolism 2010;95:1210-1220.
35. Newsom S.A., Schenk S., Li M., Everett A.C., and Horowitz J.F. High fatty acid availability after exercise alters the regulation of muscle lipid metabolism Metabolism 2010 [Epub ahead of print]
36. Nuutila P., Knuuti M.J., and Maki M. Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography Diabetes 44 1995 31 36
37. Yki-Jarvinen H. Sex and insulin sensitivity Metabolism 33 1984 1011 1015 (Pubitemid 15210835)
38. Loviscach M., Rehman N., and Carter L. Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action Diabetologia 43 2000 304 311 (Pubitemid 30163473)
39. Catapano A.L. Mode of action of fibrates Pharmacol Res 26 1992 331 340 (Pubitemid 23036557)
40. Shepherd J. Mechanism of action of fibrates Postgrad Med J 69 1993 S34 S41
41. Ginsberg HN, Elam MB, Lovato LC, et al. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010;362:1563-1574.